[HTML][HTML] Therapeutic selectivity and the multi-node drug target
J Lehar, AS Krueger, GR Zimmermann… - Discovery …, 2009 - discoverymedicine.com
Drug combinations are an increasingly favored strategy for increasing therapeutic windows
for potential drugs, but enthusiasm for this approach is tempered by concerns that …
for potential drugs, but enthusiasm for this approach is tempered by concerns that …
[HTML][HTML] Therapeutic Selectivity and the Multi-node Drug Target
J Lehar, AS Krueger, GR Zimmermann… - Discovery …, 2009 - discoverymedicine.com
Drug combinations are an increasingly favored strategy for increasing therapeutic windows
for potential drugs, but enthusiasm for this approach is tempered by concerns that …
for potential drugs, but enthusiasm for this approach is tempered by concerns that …
Therapeutic selectivity and the multi-node drug target.
J Lehar, AS Krueger, GR Zimmermann… - Discovery …, 2009 - europepmc.org
Drug combinations are an increasingly favored strategy for increasing therapeutic windows
for potential drugs, but enthusiasm for this approach is tempered by concerns that …
for potential drugs, but enthusiasm for this approach is tempered by concerns that …
Therapeutic selectivity and the multi-node drug target
J Lehar, AS Krueger, GR Zimmermann… - Discovery …, 2009 - pubmed.ncbi.nlm.nih.gov
Drug combinations are an increasingly favored strategy for increasing therapeutic windows
for potential drugs, but enthusiasm for this approach is tempered by concerns that …
for potential drugs, but enthusiasm for this approach is tempered by concerns that …